Table 4.

Mean (standard error) IIEF-5 score for erectile dysfunction by age group and hyperlipidemia status^* among men contributing blood samples in the Boston Area Community Health Survey, 2002–2005, N=1899.

Age group	Total	Treated hyperlipidemia (any treatment)*	Treated with statins‡ only	Untreated hyperlipidemia	No hyperlipidemia
	Mean† (SE)	Mean† (SE)	Mean† (SE)	Mean† (SE)	Mean† (SE)
Total	20.2 (0.2)	17.0 (0.6)	17.0 (0.6)	21.6 (0.4)	20.6 (0.2)
N	1899	290	244	251	1358
30–39	21.9 (0.3)	13.7 (2.4)	15.3 (2.9)	22.5 (0.6)	22.1 (0.2)
N	512	11	7	72	429
40–49	21.0 (0.2)	19.3 (0.9)	19.1 (0.9)	22.3 (0.5)	21.0 (0.3)
N	554	62	54	86	406
50–59	19.4 (0.5)	18.1 (1.0)	17.7 (1.2)	20.2 (1.0)	19.6 (0.6)
N	436	81	65	55	300
60–69	17.6 (0.6)	16.7 (0.9)	16.6 (1.0)	18.9 (1.5)	18.1 (0.8)
N	260	91	77	27	142
70–79	14.9 (0.8)	15.2 (1.3)	15.5 (1.4)	16.4 (2.8)	14.5 (1.0)
N	137	45	41	11	81

^*Treated hyperlipidemia was defined as taking prescription anti-lipid medication, untreated hyperlipidemia was measured serum total cholesterol of ≥240 mg/dL without taking prescription anti-lipid medication, and no hyperlipidemia was defined as no use of anti-lipid medications and total serum cholesterol <240.

^†All means were weighted by the inverse of the probability of being sampled.

^‡Statins were atorvastatin, fluvastatin, lovastatin, pravastatin, rosuvastatin, or simvastatin.